Tumors are “born to be bad” with metastatic potential present from the start, spreading to other organs when the original malignancy is the size of a poppy seed, she says.
An AACR fellowship helped a young pediatrician become a physician-scientist, using clinical insights to inform the search for new cancer therapeutics in the laboratory.Learn More
Research presented at the AACR Annual Meeting highlights the great potential of liquid biopsy to benefit patients across the continuum of cancer care.Learn More
A career development grant from the American Association for Cancer Research (AACR) helped Yale cancer scientist Luisa Escobar-Hoyos, MSC, PhD, earn two major, multi-year federal grants to further develop her research.Learn More
“It worked better than our wildest dreams,” Dr. Luis Diaz said of a therapeutic approach that uses a tumor biomarker to identify patients likely to respond to immunotherapy.